Honliv Healthcare Management Group Company Limited (9906.HK)
HKD 1.54
(0.65%)
HKD 1.54
(0.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 91.55 Million | 118.47 Million | 91.44 Million | 74.61 Million | 86.04 Million | 136.96 Million |
| Net Income | 51.42 Million | 63.02 Million | 50.54 Million | 30.85 Million | 68.47 Million | 98.47 Million |
| Depreciation & Amortization | 60.23 Million | 54.75 Million | 33.71 Million | 28.5 Million | 24.47 Million | 24.08 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -31.04 Million | 10.32 Million | 3.53 Million | -12.52 Million | 56.21 Million | 1.63 Million |
| Other non-cash items | 6.61 Million | -9.62 Million | 3.65 Million | 27.78 Million | -63.12 Million | 12.76 Million |
| Investing Cash Flow | -88.76 Million | -19.16 Million | -50.46 Million | -80.06 Million | -65.01 Million | 1.88 Million |
| Investments in PPE | -89.55 Million | -19.8 Million | -51.36 Million | -80.85 Million | -65.72 Million | -6.92 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 491 Thousand | 647 Thousand | 903 Thousand | 791 Thousand | 706 Thousand | 8.81 Million |
| Financing Cash Flow | -19.11 Million | -117.84 Million | -76.87 Million | 215.15 Million | 73.64 Million | -139.01 Million |
| Debt repayment | -35.53 Million | -210 Million | -246.76 Million | -237.92 Million | -353.41 Million | -459.67 Million |
| Dividends payments | - | - | - | -7.22 Million | -9.57 Million | -45.7 Million |
| Common Stock Repurchased | -45.92 Million | -61.3 Million | - | - | - | - |
| Common Stock Issuance | -45.92 Million | -61.3 Million | - | 283.88 Million | - | - |
| Other Financing Activities | -7.64 Million | 276.07 Million | 169.89 Million | 176.42 Million | 436.63 Million | 366.35 Million |
| Accounts receivables | 419 Thousand | -14.82 Million | -15.52 Million | -6.67 Million | 25.86 Million | -26.63 Million |
| Accounts payables | - | 14.82 Million | 15.52 Million | 6.67 Million | -25.86 Million | - |
| Inventory | -2.35 Million | -2.36 Million | -6.43 Million | 2.41 Million | -5.15 Million | -5.48 Million |
| Other working capital | -51.84 Million | 12.68 Million | 9.96 Million | -14.94 Million | 61.36 Million | 7.11 Million |
| Cash at beginning of period | 255.23 Million | 263.61 Million | 302.47 Million | 104.6 Million | 9.93 Million | 10.09 Million |
| Cash at end of period | 239.75 Million | 255.23 Million | 263.61 Million | 302.47 Million | 104.6 Million | 9.93 Million |
| Capital Expenditure | -89.55 Million | -19.8 Million | -51.36 Million | -80.85 Million | -65.72 Million | -6.92 Million |
| Effect of forex changes on cash | 836 Thousand | 10.16 Million | -2.97 Million | -11.83 Million | - | - |
| Net cash flow / Change in cash | -15.48 Million | -8.37 Million | -38.86 Million | 197.87 Million | 94.67 Million | -168 Thousand |
| Free Cash Flow | 2 Million | 98.66 Million | 40.08 Million | -6.23 Million | 20.32 Million | 130.03 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 10.02 Million | 10.02 Million | 51.42 Million | 7.02 Million | 7.02 Million | 12.13 Million |
| Depreciation & Amortization | 17.73 Million | 17.73 Million | 60.23 Million | 15.67 Million | 15.67 Million | 14.44 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -31.04 Million | -26.88 Million | -26.88 Million | - |
| Other non-cash items | 918.5 Thousand | 918.5 Thousand | 6.61 Million | 26.76 Million | 26.76 Million | -3.36 Million |
| Investing Cash Flow | -11.48 Million | -11.48 Million | -88.76 Million | -25.48 Million | -25.48 Million | -18.89 Million |
| Investments in PPE | -10.75 Million | -10.75 Million | -89.55 Million | -25.87 Million | -25.87 Million | -18.74 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -734.5 Thousand | -734.5 Thousand | 491 Thousand | 394.5 Thousand | 394.5 Thousand | -149 Thousand |
| Financing Cash Flow | -6.98 Million | -6.98 Million | -19.11 Million | -14.29 Million | -14.29 Million | 4.73 Million |
| Debt repayment | - | - | -35.53 Million | - | - | -31.75 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -45.92 Million | -15.41 Million | -15.41 Million | -7.54 Million |
| Common Stock Issuance | - | - | -45.92 Million | - | - | - |
| Other Financing Activities | -6.98 Million | -6.98 Million | -7.64 Million | 1.11 Million | 1.11 Million | 12.28 Million |
| Accounts receivables | - | - | 419 Thousand | 209.5 Thousand | 209.5 Thousand | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -2.35 Million | -1.17 Million | -1.17 Million | - |
| Other working capital | - | - | -51.84 Million | -25.92 Million | -25.92 Million | - |
| Cash at beginning of period | - | - | 255.23 Million | -418 Thousand | -418 Thousand | 286.56 Million |
| Cash at end of period | 10.22 Million | 10.22 Million | 239.75 Million | -17.71 Million | -17.71 Million | 295.97 Million |
| Capital Expenditure | -10.75 Million | -10.75 Million | -89.55 Million | -25.87 Million | -25.87 Million | -18.74 Million |
| Effect of forex changes on cash | 22 Thousand | 22 Thousand | 836 Thousand | -91 Thousand | -91 Thousand | 509 Thousand |
| Net cash flow / Change in cash | 10.22 Million | 10.22 Million | -15.48 Million | -17.29 Million | -17.29 Million | 9.4 Million |
| Free Cash Flow | 17.91 Million | 17.91 Million | 2 Million | -3.3 Million | -3.3 Million | 4.45 Million |
8917
MTMH
VLI
E2E
PSC
BFINVEST